1-3 of 3
Nicolas Thonnart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Involvement of the CD39/CD73/adenosine pathway in T-cell proliferation and NK cell-mediated antibody-dependent cell cytotoxicity in Sézary syndrome

Gabrielle Sonigo, Alizée Bozonnat, Maëlle Dumont, Nicolas Thonnart, Caroline Ram-Wolff, Adèle de Masson, Martine Bagot, Armand Bensussan, Anne Marie-Cardine
Journal: Blood
Blood (2022) 139 (17): 2712–2716.
https://doi.org/10.1182/blood.2021014782
Published: 2022
Includes: Supplemental data
Journal Articles

First-in-Human, Multicenter Phase I Study of IPH4102, First-in-Class Humanized Anti-KIR3DL2 Monoclonal Antibody, in Relapsed/Refractory Cutaneous T-Cell Lymphomas: Preliminary Safety, Exploratory and Clinical Activity Results

Martine Bagot, MD, Pierluigi Porcu, MD, Caroline Ram-Wolff, MD, Michael Khodadoust, MD PhD, Maxime Battistella, MD, Anne Marie-Cardine, PhD, Steve Mathieu, MD, Maarten H. Vermeer, MD PhD, Sean Whittaker, MB, ChB, FRCP, MD, Madeleine Duvic, MD, Armand Bensussan, PhD, Carine Paturel, PhD, Cecile Bonnafous, PhD, Nicolas Thonnart, Agnes Widemann, PharmD, Cecile Bonin, PharmD, Helene Sicard, PhD, Christine Paiva, Korinna Pilz, MD, Youn Kim, MD
Journal: Blood
Blood (2016) 128 (22): 1826.
https://doi.org/10.1182/blood.V128.22.1826.1826
Published: 2016
Journal Articles

KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell death

Nicolas Thonnart, Anne Caudron, Isabel Legaz, Martine Bagot, Armand Bensussan, Anne Marie-Cardine
Journal: Blood
Blood (2014) 124 (22): 3330–3332.
https://doi.org/10.1182/blood-2014-09-598995
Published: 2014